All In MedTech

FDA Clearance Tracker · P130024

LUTONIX DRUG COATED BALLOON PTA CATETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 9, 2014 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Oct 9, 2014

Approved

Time to decision

318 days

Received Nov 25, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P130024
Device name
LUTONIX DRUG COATED BALLOON PTA CATETER
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Nov 25, 2013
Decided
Oct 9, 2014
Decision
Approved
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
41 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code ONU

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE LUTONIX 035 DRUG COATED BALLOON PTA CATHETER (LUTONIX DCB). THIS DEVICE IS INDICATED FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, AFTER PRE-DILATATION, OF DE NOVO OR RESTENOTIC LESIONS UP TO 150MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL OR POPLITEAL ARTERIES WITH REFERENCE VESSELDIAMETERS OF 4-6MM.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code ONU (Drug-Eluting Peripheral Transluminal Angioplasty Catheter).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.